Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2026-07-22 20:06:15 ET · period of report 2026-07-15 · accession 0001140361-26-029341 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-22 20:06 | 2026-07-15 | ANGO | REED JAN STERN | Dir | A - Grant | $0.00 | +11.9K | 116.9K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-15 | A | A | 11,887 | $0.00 | 116,921 | D | — | — | (F1) The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. |